On November 18, 2024, we entered into an unsecured convertible promissory note ("Note Purchase Agreement") with an accredited investor ("Investor") for proceeds of up to $200,000 to be used for gener…
On May 4, 2022 we exercised our rights under the License Option Agreement and entered into a license agreement with CWRU ("License Agreement"). Pursuant to the terms of the License Agreement, we agre…
On July 1, 2024, we entered into a Master Services Agreement with Oncotelic whereby we perform advisory and related services in connection with studies and projects. During the years ended December 3…
Mosaic ImmunoEngineering, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CPMV-DEBT
Debt stack $1.7M
90%
Market cache reports total debt of $1.7M.
CPMV-DEBT-8818
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2023-12-31.
Mosaic ImmunoEngineering, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Mosaic ImmunoEngineering, Inc..
Mosaic ImmunoEngineering, Inc. Ownership
No ownership data on recordNo major institutional ownership relationships found in our database for Mosaic ImmunoEngineering, Inc..
Mosaic ImmunoEngineering, Inc. Extended Supply Chain Network